{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T05:53:07Z","timestamp":1764827587889,"version":"3.37.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200701","82470633"],"award-info":[{"award-number":["82200701","82470633"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","award":["20220484086"],"award-info":[{"award-number":["20220484086"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2020YFA0113500"],"award-info":[{"award-number":["2020YFA0113500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-89796-2","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T03:43:13Z","timestamp":1739331793000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["BRISC inactivation alleviates alcohol-induced liver injury in mice"],"prefix":"10.1038","volume":"15","author":[{"given":"Ting","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang-Ming","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shen-Si","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Qun","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Ying","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong-Hua","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,12]]},"reference":[{"key":"89796_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41572-018-0014-7","volume":"4","author":"HK Seitz","year":"2018","unstructured":"Seitz, H. K. et al. Alcoholic liver disease. Nat. Rev. Dis. Primers. 4, 16. https:\/\/doi.org\/10.1038\/s41572-018-0014-7 (2018).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"89796_CR2","doi-asserted-by":"publisher","unstructured":"Mackowiak, B., Fu, Y., Maccioni, L. & Gao, B. Alcohol-associated liver disease. J. Clin. Invest. 134 https:\/\/doi.org\/10.1172\/jci176345 (2024).","DOI":"10.1172\/jci176345"},{"key":"89796_CR3","doi-asserted-by":"publisher","unstructured":"Pohl, K., Moodley, P. & Dhanda, A. D. Alcohol\u2019s Impact on the Gut and Liver. Nutrients 13 https:\/\/doi.org\/10.3390\/nu13093170 (2021).","DOI":"10.3390\/nu13093170"},{"key":"89796_CR4","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s12967-023-04166-8","volume":"21","author":"C Yan","year":"2023","unstructured":"Yan, C. et al. Pathogenic mechanisms and regulatory factors involved in alcoholic liver disease. J. Transl Med. 21, 300. https:\/\/doi.org\/10.1186\/s12967-023-04166-8 (2023).","journal-title":"J. Transl Med."},{"key":"89796_CR5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1146\/annurev-pathmechdis-031521-030435","volume":"18","author":"X Wu","year":"2023","unstructured":"Wu, X. et al. Recent advances in understanding of Pathogenesis of Alcohol-Associated Liver Disease. Annu. Rev. Pathol. 18, 411\u2013438. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-031521-030435 (2023).","journal-title":"Annu. Rev. Pathol."},{"key":"89796_CR6","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/hep.0000000000000381","volume":"80","author":"AK Singal","year":"2024","unstructured":"Singal, A. K., Shah, V. H. & Malhi, H. Emerging targets for therapy in ALD: lessons from NASH. Hepatology 80, 223\u2013237. https:\/\/doi.org\/10.1097\/hep.0000000000000381 (2024).","journal-title":"Hepatology"},{"key":"89796_CR7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.livres.2024.06.002","volume":"8","author":"X Wang","year":"2024","unstructured":"Wang, X., Wang, J., Peng, H., Zuo, L. & Wang, H. Role of immune cell interactions in alcohol-associated liver diseases. Liver Res. 8, 72\u201382. https:\/\/doi.org\/10.1016\/j.livres.2024.06.002 (2024).","journal-title":"Liver Res."},{"key":"89796_CR8","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1016\/j.ajpath.2020.08.014","volume":"190","author":"E Slevin","year":"2020","unstructured":"Slevin, E. et al. Kupffer cells: inflammation pathways and cell-cell interactions in Alcohol-Associated Liver Disease. Am. J. Pathol. 190, 2185\u20132193. https:\/\/doi.org\/10.1016\/j.ajpath.2020.08.014 (2020).","journal-title":"Am. J. Pathol."},{"key":"89796_CR9","doi-asserted-by":"publisher","first-page":"538","DOI":"10.3389\/fimmu.2016.00538","volume":"7","author":"T Zeng","year":"2016","unstructured":"Zeng, T., Zhang, C. L., Xiao, M., Yang, R. & Xie, K. Q. Critical roles of Kupffer Cells in the Pathogenesis of Alcoholic Liver Disease: from Basic Science to clinical trials. Front. Immunol. 7, 538. https:\/\/doi.org\/10.3389\/fimmu.2016.00538 (2016).","journal-title":"Front. Immunol."},{"key":"89796_CR10","doi-asserted-by":"publisher","first-page":"1215333","DOI":"10.3389\/fimmu.2023.1215333","volume":"14","author":"S Brahadeeswaran","year":"2023","unstructured":"Brahadeeswaran, S., Dasgupta, T., Manickam, V., Saraswathi, V. & Tamizhselvi, R. NLRP3: a new therapeutic target in alcoholic liver disease. Front. Immunol. 14, 1215333. https:\/\/doi.org\/10.3389\/fimmu.2023.1215333 (2023).","journal-title":"Front. Immunol."},{"key":"89796_CR11","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1055\/s-0040-1708540","volume":"40","author":"J Knorr","year":"2020","unstructured":"Knorr, J., Wree, A., Tacke, F. & Feldstein, A. E. The NLRP3 inflammasome in alcoholic and Nonalcoholic Steatohepatitis. Semin Liver Dis. 40, 298\u2013306. https:\/\/doi.org\/10.1055\/s-0040-1708540 (2020).","journal-title":"Semin Liver Dis."},{"key":"89796_CR12","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nrgastro.2015.94","volume":"12","author":"G Szabo","year":"2015","unstructured":"Szabo, G. & Petrasek, J. Inflammasome activation and function in liver disease. Nat. Rev. Gastroenterol. Hepatol. 12, 387\u2013400. https:\/\/doi.org\/10.1038\/nrgastro.2015.94 (2015).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"89796_CR13","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1172\/jci60777","volume":"122","author":"J Petrasek","year":"2012","unstructured":"Petrasek, J. et al. IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J. Clin. Invest. 122, 3476\u20133489. https:\/\/doi.org\/10.1172\/jci60777 (2012).","journal-title":"J. Clin. Invest."},{"key":"89796_CR14","doi-asserted-by":"publisher","first-page":"153864","DOI":"10.1016\/j.tox.2024.153864","volume":"506","author":"Y Shen","year":"2024","unstructured":"Shen, Y. et al. MLKL deficiency alleviates acute alcoholic liver injury via inhibition of NLRP3 inflammasome. Toxicology 506, 153864. https:\/\/doi.org\/10.1016\/j.tox.2024.153864 (2024).","journal-title":"Toxicology"},{"key":"89796_CR15","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.molcel.2015.07.028","volume":"59","author":"E Zeqiraj","year":"2015","unstructured":"Zeqiraj, E. et al. Higher-Order Assembly of BRCC36-KIAA0157 is required for DUB activity and biological function. Mol. Cell. 59, 970\u2013983. https:\/\/doi.org\/10.1016\/j.molcel.2015.07.028 (2015).","journal-title":"Mol. Cell."},{"key":"89796_CR16","doi-asserted-by":"publisher","unstructured":"Ren, G. et al. ABRO1 promotes NLRP3 inflammasome activation through regulation of NLRP3 deubiquitination. Embo j. 38 https:\/\/doi.org\/10.15252\/embj.2018100376 (2019).","DOI":"10.15252\/embj.2018100376"},{"key":"89796_CR17","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.molcel.2012.11.009","volume":"49","author":"BF Py","year":"2013","unstructured":"Py, B. F., Kim, M. S., Vakifahmetoglu-Norberg, H. & Yuan, J. Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity. Mol. Cell. 49, 331\u2013338. https:\/\/doi.org\/10.1016\/j.molcel.2012.11.009 (2013).","journal-title":"Mol. Cell."},{"key":"89796_CR18","doi-asserted-by":"publisher","unstructured":"Rabl, J. BRCA1-A and BRISC: multifunctional molecular machines for Ubiquitin Signaling. Biomolecules 10 https:\/\/doi.org\/10.3390\/biom10111503 (2020).","DOI":"10.3390\/biom10111503"},{"key":"89796_CR19","doi-asserted-by":"publisher","unstructured":"Ren, G. M. et al. Pharmacological targeting of NLRP3 deubiquitination for treatment of NLRP3-associated inflammatory diseases. Sci. Immunol. 6 https:\/\/doi.org\/10.1126\/sciimmunol.abe2933 (2021).","DOI":"10.1126\/sciimmunol.abe2933"},{"key":"89796_CR20","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.celrep.2013.08.025","volume":"5","author":"H Zheng","year":"2013","unstructured":"Zheng, H. et al. A BRISC-SHMT complex deubiquitinates IFNAR1 and regulates interferon responses. Cell. Rep. 5, 180\u2013193. https:\/\/doi.org\/10.1016\/j.celrep.2013.08.025 (2013).","journal-title":"Cell. Rep."},{"key":"89796_CR21","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/s41419-023-06268-z","volume":"14","author":"W Zhang","year":"2023","unstructured":"Zhang, W. et al. BRISC is required for optimal activation of NF-\u03baB in Kupffer cells induced by LPS and contributes to acute liver injury. Cell. Death Dis. 14, 743. https:\/\/doi.org\/10.1038\/s41419-023-06268-z (2023).","journal-title":"Cell. Death Dis."},{"key":"89796_CR22","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nprot.2013.032","volume":"8","author":"A Bertola","year":"2013","unstructured":"Bertola, A., Mathews, S., Ki, S. H., Wang, H. & Gao, B. Mouse model of chronic and binge ethanol feeding (the NIAAA model). Nat. Protoc. 8, 627\u2013637. https:\/\/doi.org\/10.1038\/nprot.2013.032 (2013).","journal-title":"Nat. Protoc."},{"key":"89796_CR23","doi-asserted-by":"publisher","unstructured":"Kitamura, H. Ubiquitin-specific proteases (USPs) and metabolic disorders. Int. J. Mol. Sci. 24 https:\/\/doi.org\/10.3390\/ijms24043219 (2023).","DOI":"10.3390\/ijms24043219"},{"key":"89796_CR24","first-page":"1647","volume":"10","author":"XY Lv","year":"2020","unstructured":"Lv, X. Y., Duan, T. & Li, J. The multiple roles of deubiquitinases in liver cancer. Am. J. Cancer Res. 10, 1647\u20131657 (2020).","journal-title":"Am. J. Cancer Res."},{"key":"89796_CR25","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1002\/jcb.30312","volume":"123","author":"E Aryapour","year":"2022","unstructured":"Aryapour, E. & Kietzmann, T. Mitochondria, mitophagy, and the role of deubiquitinases as novel therapeutic targets in liver pathology. J. Cell. Biochem. 123, 1634\u20131646. https:\/\/doi.org\/10.1002\/jcb.30312 (2022).","journal-title":"J. Cell. Biochem."},{"key":"89796_CR26","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.apsb.2022.12.006","volume":"13","author":"M Xu","year":"2023","unstructured":"Xu, M. et al. The deubiquitinating enzyme 13 retards non-alcoholic steatohepatitis via blocking inactive rhomboid protein 2-dependent pathway. Acta Pharm. Sin B. 13, 1071\u20131092. https:\/\/doi.org\/10.1016\/j.apsb.2022.12.006 (2023).","journal-title":"Acta Pharm. Sin B"},{"key":"89796_CR27","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1038\/s12276-023-01036-7","volume":"55","author":"JH Baek","year":"2023","unstructured":"Baek, J. H. et al. Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Exp. Mol. Med. 55, 1520\u20131530. https:\/\/doi.org\/10.1038\/s12276-023-01036-7 (2023).","journal-title":"Exp. Mol. Med."},{"key":"89796_CR28","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.bbrc.2023.05.100","volume":"669","author":"X Ke","year":"2023","unstructured":"Ke, X., Hu, H., Peng, Q., Ying, H. & Chu, X. USP33 promotes nonalcoholic fatty acid disease-associated fibrosis in gerbils via the c-myc signaling. Biochem. Biophys. Res. Commun. 669, 68\u201376. https:\/\/doi.org\/10.1016\/j.bbrc.2023.05.100 (2023).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"89796_CR29","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nm.4461","volume":"24","author":"YX Ji","year":"2018","unstructured":"Ji, Y. X. et al. The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis. Nat. Med. 24, 213\u2013223. https:\/\/doi.org\/10.1038\/nm.4461 (2018).","journal-title":"Nat. Med."},{"key":"89796_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2024.07.014","author":"B Zhou","year":"2024","unstructured":"Zhou, B. et al. Amelioration of nonalcoholic fatty liver disease by inhibiting the deubiquitylating enzyme RPN11. Cell. Metab. https:\/\/doi.org\/10.1016\/j.cmet.2024.07.014 (2024).","journal-title":"Cell. Metab."},{"key":"89796_CR31","doi-asserted-by":"publisher","first-page":"105594","DOI":"10.1016\/j.phrs.2021.105594","volume":"168","author":"R Yan","year":"2021","unstructured":"Yan, R. et al. Ubiquitin-specific protease 22 ameliorates chronic alcohol-associated liver disease by regulating BRD4. Pharmacol. Res. 168, 105594. https:\/\/doi.org\/10.1016\/j.phrs.2021.105594 (2021).","journal-title":"Pharmacol. Res."},{"key":"89796_CR32","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s40364-021-00320-w","volume":"9","author":"H Lei","year":"2021","unstructured":"Lei, H., Wang, J., Hu, J., Zhu, Q. & Wu, Y. Deubiquitinases in hematological malignancies. Biomark. Res. 9, 66. https:\/\/doi.org\/10.1186\/s40364-021-00320-w (2021).","journal-title":"Biomark. Res."},{"key":"89796_CR33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.molcel.2021.10.027","volume":"82","author":"SM Lange","year":"2022","unstructured":"Lange, S. M., Armstrong, L. A., Kulathu, Y. & Deubiquitinases From mechanisms to their inhibition by small molecules. Mol. Cell. 82, 15\u201329. https:\/\/doi.org\/10.1016\/j.molcel.2021.10.027 (2022).","journal-title":"Mol. Cell."},{"key":"89796_CR34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrd.2017.152","volume":"17","author":"JA Harrigan","year":"2018","unstructured":"Harrigan, J. A., Jacq, X., Martin, N. M. & Jackson, S. P. Deubiquitylating enzymes and drug discovery: emerging opportunities. Nat. Rev. Drug Discov. 17, 57\u201378. https:\/\/doi.org\/10.1038\/nrd.2017.152 (2018).","journal-title":"Nat. Rev. Drug Discov"},{"key":"89796_CR35","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1182\/blood-2018-10-877563","volume":"133","author":"R Donaghy","year":"2019","unstructured":"Donaghy, R. et al. The BRISC deubiquitinating enzyme complex limits hematopoietic stem cell expansion by regulating JAK2 K63-ubiquitination. Blood 133, 1560\u20131571. https:\/\/doi.org\/10.1182\/blood-2018-10-877563 (2019).","journal-title":"Blood"},{"key":"89796_CR36","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.ajhg.2011.04.017","volume":"88","author":"S Miskinyte","year":"2011","unstructured":"Miskinyte, S. et al. Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with syndromic moyamoya. Am. J. Hum. Genet. 88, 718\u2013728. https:\/\/doi.org\/10.1016\/j.ajhg.2011.04.017 (2011).","journal-title":"Am. J. Hum. Genet."},{"key":"89796_CR37","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1161\/circulationaha.123.066430","volume":"150","author":"H Shen","year":"2024","unstructured":"Shen, H. et al. BRCC3 regulation of ALK2 in vascular smooth muscle cells: implication in Pulmonary Hypertension. Circulation 150, 132\u2013150. https:\/\/doi.org\/10.1161\/circulationaha.123.066430 (2024).","journal-title":"Circulation"},{"key":"89796_CR38","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.ymthe.2023.01.011","volume":"31","author":"T Wang","year":"2023","unstructured":"Wang, T. et al. ABRO1 arrests cardiomyocyte proliferation and myocardial repair by suppressing PSPH. Mol. Ther. 31, 847\u2013865. https:\/\/doi.org\/10.1016\/j.ymthe.2023.01.011 (2023).","journal-title":"Mol. Ther."},{"key":"89796_CR39","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1053\/jhep.2001.25350","volume":"34","author":"T Uesugi","year":"2001","unstructured":"Uesugi, T., Froh, M., Arteel, G. E., Bradford, B. U. & Thurman, R. G. Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice. Hepatology 34, 101\u2013108. https:\/\/doi.org\/10.1053\/jhep.2001.25350 (2001).","journal-title":"Hepatology"},{"key":"89796_CR40","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/hep.0000000000000298","volume":"78","author":"M de Carvalho Ribeiro","year":"2023","unstructured":"de Carvalho Ribeiro, M. et al. Alcohol-induced extracellular ASC specks perpetuate liver inflammation and damage in alcohol-associated hepatitis even after alcohol cessation. Hepatology 78, 225\u2013242. https:\/\/doi.org\/10.1097\/hep.0000000000000298 (2023).","journal-title":"Hepatology"},{"key":"89796_CR41","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","volume":"4","author":"RA Irizarry","year":"2003","unstructured":"Irizarry, R. A. et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4, 249\u2013264. https:\/\/doi.org\/10.1093\/biostatistics\/4.2.249 (2003).","journal-title":"Biostatistics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89796-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89796-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89796-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T15:25:50Z","timestamp":1739373950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89796-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,12]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["89796"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-89796-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,2,12]]},"assertion":[{"value":"22 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5154"}}